A4 Amyloid Beta
Amyloid-beta 1-42, the aggregation-prone peptide fragment of amyloid precursor protein, studied extensively in Alzheimer's disease research.
Amino-acid chains studied as signaling molecules, including growth hormone secretagogues, repair peptides, melanocortins, and neuropeptides.
Amyloid-beta 1-42, the aggregation-prone peptide fragment of amyloid precursor protein, studied extensively in Alzheimer's disease research.
Modified fragment of the C-terminus of human growth hormone, studied for effects on lipolysis and fat metabolism.
Synthetic hexapeptide developed by Lipotec; the prototypical topical neurocosmetic peptide, studied in expression-line research.
Body Protection Compound-157, a synthetic peptide derived from a gastric protein, studied for gastric and connective-tissue repair.
A research blend pairing BPC-157 and TB-500, two peptides studied together for tissue-repair and recovery applications.
Growth hormone-releasing hormone analog incorporating a Drug Affinity Complex, studied for extended growth hormone elevation.
Delta sleep-inducing peptide, an endogenous neuropeptide studied for its influence on sleep regulation and the stress response.
Synthetic tetrapeptide modeled on a pineal gland peptide, developed in Russia and studied in telomerase and aging research.
Recombinant form of the follistatin glycoprotein, studied as a myostatin-binding regulator in muscle-growth research.
Copper-binding tripeptide complex naturally present in human plasma, studied for skin remodeling and wound-healing research.
Synthetic growth hormone-releasing peptide and ghrelin receptor agonist, studied for stimulation of growth hormone secretion.
First-generation growth hormone-releasing peptide and ghrelin receptor agonist, studied for growth hormone release and appetite signaling.
A research peptide blend of GHK-Cu, BPC-157 and TB-500, studied together for skin, recovery and connective-tissue research.
Synthetic growth hormone secretagogue and ghrelin receptor agonist, studied for growth hormone release and cardiovascular research.
Truncated analog of insulin-like growth factor 1 missing three N-terminal residues, studied for localized growth-factor signaling.
Long-acting analog of insulin-like growth factor 1 with an extended half-life, studied for anabolic and growth-factor signaling research.
Selective growth hormone secretagogue and ghrelin receptor agonist, studied for growth hormone release with minimal effect on other hormones.
Active fragment of the kisspeptin neuropeptide, studied for its role in initiating gonadotropin-releasing hormone secretion.
A multi-peptide research blend of GHK-Cu, BPC-157, TB-500 and KPV, studied for combined skin, recovery and anti-inflammatory research.
Tripeptide fragment of alpha-melanocyte-stimulating hormone, studied for anti-inflammatory activity in gut and skin research.
Palmitoylated pentapeptide (Palmitoyl Pentapeptide-4), studied as a matrix-stimulating peptide in topical skin research.
Synthetic cyclic analog of alpha-melanocyte-stimulating hormone, studied for melanogenesis and sexual-function research.
Modified growth hormone-releasing hormone analog, studied for stimulation of endogenous growth hormone secretion.
Mitochondrial-derived peptide encoded within mitochondrial DNA, studied for its role in metabolic regulation and exercise physiology.
Endogenous neuropeptide hormone produced in the hypothalamus, studied for roles in social bonding, lactation and reproductive physiology.
Cyclic melanocortin receptor agonist derived from melanotan II, studied for effects on sexual arousal in neuroendocrine research.
Synthetic analog of the immunomodulatory peptide tuftsin, developed in Russia and studied for anxiolytic and immune-regulating activity.
Synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone, developed in Russia and studied for nootropic and neuroprotective activity.
Synthetic analog of growth hormone-releasing hormone, studied for stimulation of endogenous growth hormone secretion.
Synthetic version of the active region of thymosin beta-4, studied for actin regulation in tissue-repair research.
Stabilized growth hormone-releasing hormone analog developed by Theratechnologies, studied for reduction of visceral adipose tissue.
Immunomodulatory peptide derived from thymosin fraction 5, studied for regulation of T-cell function in immune research.
Synthetic gonadotropin-releasing hormone agonist, studied for its effects on the hypothalamic-pituitary-gonadal axis.